Hannah Robinson
Clinical delivery lead
I have been a qualified paediatric nurse since 1997. During this time I have worked in general paediatrics and paediatric specialist surgery, with a particular focus on neurosurgery. I have worked for OVG since June 2008, where I have been the lead nurse on studies researching new vaccines against meningitis type B and carriage studies. In my role as a senior research nurse I have joint line management responsibility for the clinical research fellows and responsibility for some of the paediatric research nurses, this includes supporting and developing their career. With the other senior research nurse I form part of a team that reviews new studies and begins the study setup process, before the study is handed over to a research nurse in the ‘lead nurse’ role and a ‘lead Dr’.
Recent publications
-
Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in HIV infection: a single-arm sub-study of a phase 2/3 clinical trial
Journal article
EWER K. et al, (2021), Lancet HIV
-
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial (vol 396, pg 467, 2020)
Journal article
Folegatti P. et al, (2020), LANCET, 396, 466 - 466
-
Presumed Risk Factors and Biomarkers for Severe Respiratory Syncytial Virus Disease and Related Sequelae: Protocol for an Observational Multicenter, Case-Control Study From the Respiratory Syncytial Virus Consortium in Europe (RESCEU).
Journal article
Jefferies K. et al, (2020), The Journal of infectious diseases
-
Respiratory Syncytial Virus Consortium in Europe (RESCEU) Birth Cohort Study: Defining the Burden of Infant Respiratory Syncytial Virus Disease in Europe.
Journal article
Wildenbeest JG. et al, (2020), The Journal of infectious diseases
-
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial
Journal article
HODGSON S., (2020), The Lancet